immunosuppressives (Molecumetics/BMS)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameimmunosuppressives (Molecumetics/BMS)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicMultiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecumetics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecumetics LtdBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicMultiple SclerosisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A